2018至2021年全球院外心脏骤停特征:国际复苏联络委员会(ILCOR)研究与登记委员会第三次报告
国际复苏联络委员会(ILCOR)研究与登记委员会邀请全球基于人群的院外心脏骤停登记处自愿参与,纳入经紧急医疗服务治疗的院外心脏骤停,收集2018至2021年Utstein模板核心要素的描述性汇总数据。共纳入来自北美、欧洲、亚洲和大洋洲的13个国家登记处和5个地区登记处。2021年旁观者心肺复苏实施率为9.6%至83.8%(中位数61.7%),公共可及自动体外除颤器除颤为0.5%至11.7%(中位数2.3%);旁观者目击的可除颤院外心脏骤停出院生存或30天生存为19.9%至44.4%(中位数28.3%),神经功能良好结局为9.5%至35.1%(中位数22.0%)。多数登记处显示2020-2021年新冠疫情期间生存率和神经功能良好结局低于2018-2019年。
要点
- 2021年旁观者心肺复苏实施率在各登记处间为9.6%至83.8%(中位数61.7%),差异巨大。
- 2021年公共可及自动体外除颤器除颤率仅为0.5%至11.7%(中位数2.3%)。
- 旁观者目击的可除颤院外心脏骤停出院生存或30天生存为19.9%至44.4%(中位数28.3%)。
- 神经功能良好结局为9.5%至35.1%(中位数22.0%)。
- 多数登记处显示2020-2021年新冠疫情期间生存率和神经功能良好结局低于2018-2019年。
适用人群与场景
- 经紧急医疗服务治疗的院外心脏骤停患者,来自13个国家登记处和5个地区登记处,覆盖北美、欧洲、亚洲和大洋洲。
研究设计与关键结果
- 研究类型为国际多登记处描述性汇总报告,纳入18个登记处(13个国家登记处和5个地区登记处),收集2018至2021年Utstein模板核心要素数据。
- 2021年旁观者心肺复苏实施率范围为9.6%至83.8%(中位数61.7%)。
- 2021年公共可及自动体外除颤器除颤率范围为0.5%至11.7%(中位数2.3%)。
- 2021年旁观者目击的可除颤院外心脏骤停出院生存或30天生存范围为19.9%至44.4%(中位数28.3%)。
- 2021年神经功能良好结局范围为9.5%至35.1%(中位数22.0%)。
- 多数登记处显示2020-2021年新冠疫情期间生存率和神经功能良好结局低于2018-2019年。
证据类型、等级与局限
- 证据类型为国际登记处描述性汇总报告,非随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
指南或共识出处
- 国际复苏联络委员会(ILCOR)研究与登记委员会第三次报告,发表于Resuscitation。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The International Liaison Committee on Resuscitation (ILCOR) Research and Registries Committee previously reported 2015 data on systems of care and outcomes for out-of-hospital cardiac arrest (OHCA) from 16 registries and 2015 to 2017 data from 15 registries. To describe updated data on OHCA, we report the characteristics of OHCAs from 2018 through 2021.
METHODS: We invited national and regional population-based OHCA registries to participate voluntarily and included emergency medical services-treated OHCAs. We collected descriptive summary data of core elements of the Utstein OHCA registry template from 2018 through 2021 at each registry.
RESULTS: Thirteen national and five regional registries from North America, Europe, Asia, and Oceania were included in this report. The provision of bystander cardiopulmonary resuscitation ranged from 9.6 % to 83.8 % (median 61.7 %) and shocks by public access automated external defibrillator from 0.5 % to 11.7 % (median 2.3 %) in 2021. Survival to hospital discharge or 30-day survival for bystander-witnessed shockable OHCA ranged from 19.9 % to 44.4 % (median 28.3 %), and neurologically favourable outcome ranged from 9.5 % to 35.1 % (median 22.0 %) in 2021. The majority of registries showed that survival and favourable neurological outcomes were lower in the 2020-2021 COVID-19 pandemic period compared with those in 2018-2019.
CONCLUSION: This report from ILCOR presents summary data for OHCA systems of care and outcomes from 2018 through 2021 from 18 national and regional OHCA registries worldwide. We observed a persisting wide variability in OHCA characteristics and outcomes across registries and the potential impact of the COVID-19 pandemic within registries.
参考来源
- Nishiyama C, Kiguchi T, Okubo M, et al. Characteristics of out-of-hospital cardiac arrest from 2018 to 2021 across the world: third report from the International Liaison Committee on Resuscitation (ILCOR) research and registries committee. Resuscitation. 2025. PMID: 41033602. doi:10.1016/j.resuscitation.2025.110852
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。